AVTR

AVTR

USD

Avantor Inc. Common Stock

$13.585+0.155 (1.154%)

Prix en Temps Réel

Healthcare
Medical Instruments & Supplies
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$13.430

Haut

$13.745

Bas

$13.405

Volume

9.68M

Fondamentaux de l'Entreprise

Capitalisation Boursière

9.3B

Industrie

Medical Instruments & Supplies

Pays

United States

Statistiques de Trading

Volume Moyen

11.95M

Bourse

NYQ

Devise

USD

Intervalle sur 52 Semaines

Bas $11.82Actuel $13.585Haut $28

Actualités Connexes

PR Newswire

Avantor® to Participate in the 2025 RBC Capital Markets Global Healthcare Conference

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced...

Voir plus
Avantor® to Participate in the 2025 RBC Capital Markets Global Healthcare Conference
PR Newswire

Avantor® to Participate in Bank of America Securities 2025 Health Care Conference

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced...

Voir plus
Avantor® to Participate in Bank of America Securities 2025 Health Care Conference
Analyst Upgrades

Goldman Sachs Downgrades Avantor to Neutral, Lowers Price Target to $14

Goldman Sachs analyst Matthew Sykes downgrades Avantor from Buy to Neutral and lowers the price target from $23 to $14.

Voir plus
Goldman Sachs Downgrades Avantor to Neutral, Lowers Price Target to $14
Analyst Upgrades

RBC Capital Maintains Outperform on Avantor, Lowers Price Target to $20

RBC Capital analyst Conor McNamara maintains Avantor with a Outperform and lowers the price target from $24 to $20.

Voir plus
RBC Capital Maintains Outperform on Avantor, Lowers Price Target to $20
Analyst Upgrades

Stifel Downgrades Avantor to Hold, Lowers Price Target to $14

Stifel analyst Daniel Arias downgrades Avantor from Buy to Hold and lowers the price target from $26 to $14.

Voir plus
Stifel Downgrades Avantor to Hold, Lowers Price Target to $14
Analyst Upgrades

Morgan Stanley Downgrades Avantor to Equal-Weight, Lowers Price Target to $15

Morgan Stanley analyst Tejas Savant downgrades Avantor from Overweight to Equal-Weight and lowers the price target from $25 to $15.

Analyst Upgrades

Baird Maintains Outperform on Avantor, Lowers Price Target to $17

Baird analyst Catherine Schulte maintains Avantor with a Outperform and lowers the price target from $21 to $17.

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.